MEK inhibitors: a patent review 2008-2010

Academic Article

• Overview
• Research
• Identity
• Additional Document Info
• View All

Overview

authors

• Trujillo, John I

publication date

• July 2011

journal

• Expert Opinion on Therapeutic Patents  Journal

subject areas

• Animals
• Cell Differentiation
• Drug Delivery Systems
• Drug Design
• Enzyme Inhibitors
• Humans
• Mitogen-Activated Protein Kinase Kinases
• Neoplasms
• Patents as Topic
• Signal Transduction

Research

keywords

• ARRY-162 (ARRY-438162)
• AS703026 (MSC1936369B)
• AZD6244 (ARRY-142866)
• AZD8330 (ARRY424704)
• BAY869766 (RDEA119)
• CI-1040
• CI-1040/PD-184352
• GSK1120212 (JTP-74057)
• GSK2118436
• MAPK
• MEK
• MEK inhibitor
• MEK1
• MEK2
• PD-0325901
• RO4987655 (CH4987655)
• RO5068760
• RO5126766
• Ras/Raf/MEK/ERK
• TAK-733
• XL518 (GDC0973)
• cancer
• extracellular signal-regulated kinase

Identity

International Standard Serial Number (ISSN)

• 1354-3776

Digital Object Identifier (DOI)

• 10.1517/13543776.2011.577068

PubMed ID

• 21548849

Additional Document Info

start page

• 1045

end page

• 1069

volume

• 21

issue

• 7